Department of Ophthalmology, Stanford University School of Medicine, Stanford, California.
Rollins School of Public Health, Department of Biostatistics and Bioinformatics, Emory University, Atlanta, Georgia.
JAMA Ophthalmol. 2020 Apr 1;138(4):365-372. doi: 10.1001/jamaophthalmol.2020.0006.
Although intraocular lenses (IOLs) are often implanted in children, little is known whether primary IOL implantation or aphakia and contact lens correction results in better long-term visual outcomes after unilateral cataract surgery during infancy.
To compare long-term visual outcomes with contact lens vs IOL correction following unilateral cataract surgery during infancy.
DESIGN, SETTING, AND PARTICIPANTS: This multicenter randomized clinical trial enrolled 114 infants with a unilateral congenital cataract who underwent cataract surgery with or without primary IOL implantation between 1 and 6 months of age. Data on long-term visual outcomes were collected when the children were age 10.5 years (July 14, 2015, to July 12, 2019) and analyzed from March 30 through August 6, 2019.
Intraocular lens implantation at the time of cataract surgery.
Best-corrected visual acuity using the electronic Early Treatment Diabetic Retinopathy Study (E-ETDRS) testing protocol. Analysis was performed on an intention-to-treat basis.
Best-corrected visual acuity was measured at age 10.5 years for 110 of the 114 patients (96%) enrolled as infants. The participants included 58 girls (53%) and 52 boys (47%). Overall, 27 of the children (25%) had good (logMAR 0.30 [Snellen equivalent, 20/40] or better) visual acuity in the treated eye (12 [22%] in the IOL group and 15 [27%] in the aphakia group), but 50 children (44%) had a visual acuity of logMAR 1.00 (Snellen equivalent, 20/200) or worse (25 [44%] in the IOL group and 25 [44%] in the aphakia group). The median logMAR acuity in the treated eye was similar in children randomized to receive an IOL at the time of cataract extraction (0.89; interquartile range [IQR], 0.33-1.43 [Snellen equivalent, 20/159]) and those who remained aphakic (0.86; IQR, 0.30-1.46 [Snellen equivalent, 20/145]) (IQR, 0.30-1.46; P = .82). Although the overall difference in median visual acuity between the 2 groups was small, the estimate was imprecise (99% CI for the difference in medians was -0.54 to 0.47).
As in previous phases of the study, visual acuity outcomes were highly variable with only 27 children (25%) achieving excellent visual acuity in their treated eye and 50 children (44%) having poor vision in the treated eye. Implanting an IOL at the time of cataract extraction was neither beneficial nor detrimental to the visual outcome.
ClinicalTrials.gov Identifier: NCT00212134.
尽管眼内晶状体(IOL)经常植入儿童体内,但对于婴儿期单侧白内障手术后,是进行初次 IOL 植入还是无晶状体和接触镜矫正,哪种方法能带来更好的长期视觉效果,目前知之甚少。
比较婴儿期单侧白内障手术后接触镜与 IOL 矫正的长期视觉效果。
设计、地点和参与者:这项多中心随机临床试验纳入了 114 名患有单侧先天性白内障的婴儿,这些婴儿在 1 至 6 个月大时接受白内障手术且(或)进行初次 IOL 植入。当儿童 10.5 岁时(2015 年 7 月 14 日至 2019 年 7 月 12 日)收集长期视觉结果数据,并于 2019 年 3 月 30 日至 8 月 6 日进行分析。
白内障手术时进行 IOL 植入。
采用电子早期治疗糖尿病视网膜病变研究(E-ETDRS)检测方案评估最佳矫正视力。采用意向治疗进行分析。
在 114 名作为婴儿入组的患者中,有 110 名(96%)在 10.5 岁时测量了最佳矫正视力。参与者包括 58 名女孩(53%)和 52 名男孩(47%)。总体而言,27 名儿童(25%)在治疗眼的视力较好(logMAR 0.30 [Snellen 等价物,20/40]或更好)(12 名[22%]在 IOL 组,15 名[27%]在无晶状体组),但 50 名儿童(44%)在治疗眼的视力为 logMAR 1.00(Snellen 等价物,20/200)或更差(25 名[44%]在 IOL 组,25 名[44%]在无晶状体组)。随机接受白内障摘除时植入 IOL 的儿童(0.89;四分位距 [IQR],0.33-1.43 [Snellen 等价物,20/159])和保持无晶状体的儿童(0.86;IQR,0.30-1.46 [Snellen 等价物,20/145])(IQR,0.30-1.46;P = .82)在治疗眼的中位 logMAR 视力相似。尽管两组间的总体差异估计值不精确(中位数差异的 99%置信区间为 -0.54 至 0.47),但估计值并不精确。
与研究的前几个阶段一样,视觉 acuity 结果高度可变,只有 27 名儿童(25%)在治疗眼获得了良好的视力,50 名儿童(44%)在治疗眼视力较差。白内障摘除时植入 IOL 既没有益处也没有坏处。
ClinicalTrials.gov 标识符:NCT00212134。